Flubromazolam is not recognized to obtain any therapeutic use, just isn't on the WHO Model Listing of Vital Medicines and has never been marketed for a medicinal product or service.A single pharmacokinetics examine confirmed that a dose of 0.5 mg flubromazolam induced solid sedative effects that lasted over ten h and induced partial amnesia for ove